Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family.
One of France's leading cancer treatment facilities, the Leon-Berard Cancer Center, is a non-profit hospital dedicated to cancer treatment and research located in the Rhone-Alpes, the second largest region in France . The addition of the CyberKnife System to the already well-equipped Radiation Oncology department, – which features five treatment accelerators, one dedicated scanner and one brachytherapy suite, – will expand the range of therapeutic options available to the center's 2,000 yearly cancer patients.
"We feel strongly that the CyberKnife VSI System will help us deliver not only more typical radiation therapy, but also allow us to treat cancer patients that would otherwise have no other options," said Christian Carrie, M.D., head of the Radiation Oncology department at CLB. "Although the CyberKnife VSI System has the capacity to deliver conventional fractionation, the main reason we chose this system is for its superior accuracy and efficiency in the treatment of moving targets, in particularly liver and prostate."
With the CyberKnife VSI System, clinicians at Leon-Berard will now be able to broaden delivery of high precision radiation therapy and radiosurgery for extracranial indications. This new expertise will increase the range of radiation treatments available at the Leon-Berard Cancer Center, which already include respiratory gating radiation therapy, extracranial stereotactic radiation therapy, interstitial brachytherapy, intensity modulated conformal radiotherapy (IMRT), and total body irradiation (TBI).